Skip to content
type1.science
Phase 3RecruitingNCT07076199

Once-weekly insulin icodec phase 3 in T1D

Novo Nordisk phase 3 trial comparing once-weekly insulin icodec with once-daily glargine U100, both with insulin aspart, in adults with type 1 diabetes.

Primary endpoints

  • Change in HbA1c

Results so far

No results posted yet.